FDA Grants RMAT Designation to Atsena Therapeutics’ Gene Therapy for X-linked Retinoschisis
The designation aims to expedite development of ATSN-201 for X-linked retinoschisis, a rare inherited retinal disease with no approved treatment.The…
APAO-AIOC 2025: Day 1 Round-Up
New Delhi, new frontiers… here’s a look inside Day 1 of APAO-AIOC 2025 “India, a journey of the soul…” they…
latest posts
